May 29, 2025
Innovation Fund Spotlight: State-of-the-Art Genome Editing To Understand Disease and Develop New Therapies
Read ArticleBlog Posts focused on: Carla J Greenbaum, MD; Lab Greenbaum
January 10, 2024
On the Brink of a Golden Age of Medicine
"I know we will reach that golden age, and BRI’s research in human immunology is the vehi¬cle that will take us there. This field has shepherded incredible advances in recent years, including new vaccines, new cancer treatments, and new and better treatment options for autoimmune disease."
March 14, 2023
Prediction and Prevention: A New Paradigm in Autoimmune Disease
The FDA recently approved teplizumab, a groundbreaking therapy that signals a paradigm shift in treating not only T1D but all autoimmune diseases.
November 17, 2022
Teplizumab FAQ: Your Questions Answered About New Therapy to Delay T1D
Scientists at the Benaroya Research Institute (BRI) and TrialNet, a global type 1 diabetes (T1D) research consortium, have spent decades working to answer a bold question: Can we stop T1D before it starts?
August 31, 2021
Beyond Insulin: Beyond BRI's Quest to Stop Type 1 Diabetes
The discovery of insulin 100 years ago transformed type 1 diabetes (T1D) from a death sentence to a chronic illness. Yet T1D is still a relentless disease with no cure.
June 15, 2021
New Drug Aims to Retrain the Immune System in T1D
What if doctors could treat type 1 diabetes (T1D) by teaching the immune system to stop attacking cells in the pancreas? BRI researchers are working with the pharmaceutical company Novo Nordisk and global research consortium T1D TrialNet, testing a new approach that aims to do just that.
March 23, 2021
Testing a Vaccine That's Changing the World
In August 2020, BRI Research Nurse Anna Barash, RN, gave some of the earliest doses of Pfizer’s COVID-19 vaccine to people in Washington. That day, she was laser-focused on following every step of a detailed protocol. The impact of her work didn’t sink in until later.
August 26, 2019
Breakthrough Study Delays Type 1 Diabetes
Megan and Madeline Coder are twins who do everything together — like ballet and even raising sheep in their hometown, Battle Ground, Washington. But in the fall of 2014, when Megan was nine, she learned she had something that Madeline didn’t: type 1 diabetes (T1D).
June 20, 2019
Personalizing Treatment for Type 1 Diabetes
BRI’s Matt Dufort, PhD, and Peter Linsley, PhD, led two new studies that could help doctors predict how quickly type 1 diabetes (T1D) will progress in some people, and match them with treatments that could slow it down. Dr.
November 7, 2018
Improving Diabetes Research Worldwide
Type 1 diabetes (T1D) is an immensely complex disease, which means it’s going to take many minds—and many approaches—to conquer it. BRI plays a key role in this fight. Here are three ways we're using our expertise to improve research worldwide.
November 7, 2018
How BRI is Fighting Type 1 Diabetes
When Merry Malnar was 11 years old, her mom took her in for a routine physical and asked the doctor to test for type 1 diabetes (T1D). Merry seemed perfectly healthy, but T1D ran in the family and her mom feared Merry would inherit it too.
